The Proof with Simon Hill

The Peptide Lie: What a Drug Developer Reveals About the Compounds Everyone Is Injecting | Dr Leigh Baxt

39 snips
Apr 21, 2026
Dr Leigh Baxt, a research scientist (PhD microbiology & immunology) who leads drug development and explains peptide science. She unpacks what peptides are and the gap between FDA-approved medicines and unregulated online products. Short takes cover why lab results often fail to translate, the risks of marketing research-only compounds as treatments, and how to evaluate peptide claims critically.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Peptides Are Just Small Protein Fragments

  • Peptides are not a new magic class; they are simply short pieces of proteins derived from normal biology.
  • Dr Leigh Baxt warns many popular peptides lack human data and mechanistic mapping despite being marketed as transformative.
INSIGHT

Drug Development Takes Years And Usually Fails

  • Drug development is long and failure is common: most ideas (>99%) fail before approval.
  • Baxt describes a 10–15 year pipeline where she only works the first 2–3 years and has seen ~5 of ~60 targets reach clinical entry.
ADVICE

Avoid Claims From Research Use Only Vendors

  • Be sceptical of vendors claiming broad clinical benefits while labeling products 'for research use only'.
  • Baxt calls that practice disingenuous and warns people are targeted with marketing despite limited human evidence.
Get the Snipd Podcast app to discover more snips from this episode
Get the app